文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Tim Crossman
发表
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
James D. Clarke, A. El-Khoueiry, B. Tran, 2023, British Journal of Cancer.